Because PD-L1-expressing PLTs were suggested to add to the array of mechanisms employed by tumour cells evading the immune attack [49], we may also infer that PLT-derived PD-L1+ MVs may be endowed with a similar pro-tumour activity. The gene discussed is CD274; the disease is neoplasm.